N., Egan, L., Mamotte, C., Stokes, R., Gunton, J
The Liraglutide Effect and Action in Diabetes (LEAD) series were 6 phase 3 RCT that showed improvement in hemoglobin A1c levels, enhanced beta cell function, weight loss, and reduced blood pressure with liraglutide alone or in combination with other oral hypoglycemic agents
Without benzyl alcohol to inhibit bacterial growth, any contamination introduced during drawing can multiply rapidly
The short half-life of the No-DAC variant ensures GH pulses remain physiological and transient, reducing the risk of desensitization observed with long-term continuous GH exposure
Actions of acetyl-L-carnitine on the hypothalamo-pituitary-gonadal system in female rats J Steroid Biochem Mol Biol 1992